Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment.
Nathan FordMarco VitoriaAjay RangarajSusan L NorrisAlexandra CalmyMeg DohertyPublished in: Journal of the International AIDS Society (2020)
On the basis of the available evidence it is uncertain whether LPV/r and other antiretrovirals improve clinical outcomes or prevent infection among patients at high risk of acquiring COVID-19.